Lakewood-Amedex Biotherapeutics Inc.
LABT· Nasdaq
Lakewood-Amedex Biotherapeutics Inc.’s Q3 2026 10-Q window runs Nov 9, 2026 to Nov 27, 2026.
Based on 2 prior 10-Q filings.
Lakewood-Amedex Biotherapeutics Inc. · CIK 2079272 · Engraved from SEC EDGAR